Dossier · DXCM · Dormant
DXCM · DexCom, Inc.
Last analysed ·
Current thesis
DXCM — research research dossier: thesis, invalidation trigger, archetype.
Invalidation trigger
Daily close below the published invalidation level (under the $71.49 bid and round-number structure), OR the theme classifier flips medtech off ACCELERATING. Hard non-overridable probe stop
Thesis status
Open commitment scored if the trigger above fires How this is scored →Current Thesis
_(no analysis yet — pending first synthesis or watchlist research)_
Bull Case
_(pending)_
Bear Case
_(pending)_
Setup & Price Structure
_(pending)_
Catalyst Calendar (next 30 days)
_(pending)_
What Would Change Our Mind
_(pending)_
Correlation Notes
_(pending)_
Related · shared themes
BFLY
Butterfly Network, Inc.
BFLY sits in an ACCELERATING medtech-diagnostics theme (, cluster-breakout) with the set's strongest momentum: top-1.7%, +33.2pp vs SPX, within 10% of 52w-high above 50/200-EMA, RSI 64, +273% StockTwits velocity the AI point-of-care ultrasound story going public. Macro RISK-ON, earnings 6+ weeks out, no timing blocker, so momentum-realignment default is act; lessons flag BFLY a +18% miss. small size + wide stop keeps optionality without reloading the losing bet.
ADPT
Adaptive Biotechnologies Corporation
Medtech ACCELERATING with explosive social (+197%) but/thesis yet BFLY is the chosen velocity probe; WATCH for confirmation.
AVR
Anteris Technologies Global Corp.
TAVR disruptor at fresh 52w-high but on momentum not news, into a live $250M ATM seller, real binary ~2028 idiosyncratic, MATURING.
AZTA
Azenta, Inc.
Medtech ACCELERATING but/thesis yet, RSI 72 extended needs research; not the cluster's cleanest expression.